Pylopass
Natural health product licensed in Canada
- Other names
- Pyloguard
- Licence holder
- Novozymes North America Inc.
- NPN or DIN-HM
- 80109712
- Status
- Active licence
- Licence date
- 5 May 2021
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus reuteri Source : Lactobacillus reuteri - cellule entière | 20 Billion organisms | Not calculated |
| Lactobacillus reuteri Source : DSM 17648 (nonviable) | 20 Billion organisms | Not calculated |
Non-medicinal ingredients
Dextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 9 years ; maximum: 12 years | 200 mg | 1 day |
| Adolescentes | minimum: 13 years ; maximum: 17 years | 200 mg | 1 day |
| Adultes | minimum: 18 years | 200 mg | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce abdominal pain related to Helicobacter pylori infection. An adjunct to physician-supervised antibiotic therapy in patients with Helicobacter pylori infections. Helps to maintain gastric health. Helps support intestinal/gastrointestinal health. Helps supports normal gastric mucosa. Clinically shown to support the reduction of Helicobacter pylori when used in conjunction with physician-supervised antibiotic therapy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80109712
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.